Headfirst Editor's Pick
"We’re entering a new era of psychedelic research, the war on this sacred drug might be over. New clinical trials are proving again that mushrooms and LSD provide effective therapy for depression, anxiety and addition. So let Dr. Christopher Timmermann of the Centre for Psychedelic Research be your guide to these new revelations, and how they’ll change society forever."
Join the Headfirst mailing list for our unbiased recommendations.
A event on Monday 19th September. The event starts at 19:00.
Psychedelic drugs have a tumultuous history. Indigenous communities have used them for healing and visionary experiences for thousands of years. More recently, they were discovered by the Western society and became central to social and artistic movements in the 1960’s… before being banned worldwide.
Now psychedelics are back in the spotlight and entering the mainstream, with clinical trials exploring their therapeutic use for mental health disorders like depression, anxiety and addiction. Groundbreaking science has uncovered that these substances have effects on the brain, affecting connectivity patterns that govern day-to-day functioning.
This talk will cover the key findings coming from contemporary research with psychedelics, and hint at what is next in store for psychedelic science and the potential impact on society at large…
Doors Open at 7pm, Talk Starts at 7.30pm, come down early and grab a drink!
Follow us on IG @seedtalks
Christopher Timmermann (PhD) is a neuroscientist and psychologist from Santiago, Chile and based at the Centre for Psychedelic Research in Imperial College London, where he conducted the first neuroimaging studies on the effects of the potent psychedelic, DMT. His work focuses on the neuroscience, psychology, beliefs and ethics of the psychedelic experience.
Entry requirements:
Now psychedelics are back in the spotlight and entering the mainstream, with clinical trials exploring their therapeutic use for mental health disorders like depression, anxiety and addiction. Groundbreaking science has uncovered that these substances have effects on the brain, affecting connectivity patterns that govern day-to-day functioning.
This talk will cover the key findings coming from contemporary research with psychedelics, and hint at what is next in store for psychedelic science and the potential impact on society at large…
Doors Open at 7pm, Talk Starts at 7.30pm, come down early and grab a drink!
Follow us on IG @seedtalks
Christopher Timmermann (PhD) is a neuroscientist and psychologist from Santiago, Chile and based at the Centre for Psychedelic Research in Imperial College London, where he conducted the first neuroimaging studies on the effects of the potent psychedelic, DMT. His work focuses on the neuroscience, psychology, beliefs and ethics of the psychedelic experience.
Entry requirements:
Tickets for similar Bristol events.
